Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ) SHZ

55.31

-2.59(-4.47%)

Updated at September 26 03:10PM

Currency In CNY

Valuation

Market Cap2.42B
Enterprise Value2.68B
P/E Ratio148.69
PEG Ratio17.35
Price/Sales Ratio11.51
Price/Book Ratio6.38
Enterprise/Revenue11.84
Enterprise/EBITDA129.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.08

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue504.36M
Revenue/Share4.8
Gross Profit419.38M
EBITDA102.94M
Net Income40.22M
Diluted EPS0.34

Balance Sheet

Total Cash71.23M
Total Cash/Share0.59
Total Debt259.7M
Total Debt/Equity0.25
Current Ratio0.97
Book Value Per Share8.79

Price History

52-Week Change138.3
52-Week High81.88
52-Week Low15.54
Moving Average 50 Days53.66
Moving Average 200 Days31.63

Statistics

Average Volume14.49M
Shares Outstanding120M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.18
Payout Ratio0.45
Last Split Factor3:2
Last Split DateApril 20, 2018